Related Experiment Video
Updated: Mar 6, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Biological Basis for Amyloidogenesis in Alzheimer's Disease
T V Andreeva1, W J Lukiw, E I Rogaev
1Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, 119991, Russia. andreeva@rogaevlab.ru.
Amyloid diseases involve protein aggregates linked to neurodegeneration, particularly Alzheimer's disease (AD). This study explores amyloid formation, the amyloid cascade hypothesis in AD, and evolutionary insights into human dementia.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Soluble cellular proteins can form insoluble amyloid aggregates with a cross-β sheet structure.
- Amyloid aggregates are hallmarks of neurodegenerative diseases like Alzheimer's disease (AD), Parkinson's disease, and prion disease.
- Age is a primary risk factor for amyloid diseases, which are prevalent in the elderly population.
Purpose of the Study:
- To present current data on amyloid formation mechanisms.
- To discuss the amyloid cascade hypothesis as a key mechanism in AD pathogenesis.
- To review evolutionary aspects of amyloidosis for insights into human-specific dementia development.
Main Methods:
- Review of latest data on amyloid formation.
- Discussion of the amyloid cascade hypothesis in Alzheimer's disease.
- Analysis of evolutionary aspects of amyloidosis.
Main Results:
- Identification of nearly three dozen misfolded proteins implicated in various amyloid diseases.
- Alzheimer's disease is the most common neurodegenerative amyloid disease, affecting over 15 million people.
- Evolutionary review provides novel perspectives on human dementia mechanisms.
Conclusions:
- Amyloid formation and the amyloid cascade are central to neurodegenerative diseases, especially AD.
- Understanding amyloidosis evolution offers insights into human-specific dementia.
- Further research into amyloid mechanisms is crucial for addressing age-related neurodegenerative diseases.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer's Disease: Treatment